Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Fulvestrant × Clear all

Phase

Status

Completed 14 Terminated 4 Recruiting 4 Unknown 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 35 Advanced Breast Cancer 5 Neoplasm Metastasis 4 Estrogen Receptor-positive Breast Cancer 2 The Neoadjuvant Therapy 1 Recurrent Uterine Corpus Carcinoma 1 Neoplasms 1 Hormone Receptor-positive Advanced Breast Cancer 1 Hormone Receptor Positive Advanced Breast Cancer 1 HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer 1 HR Positive/HER-2 Negative Breast Cancer 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Breast Neoplasm Female 1 Breast Carcinoma In Situ 1 Breast Cancer Organoids 1 Brain Neoplasms 1

Interventions

Exercise 18 Drug Therapy 16 pembrolizumab 11 Surveys and Questionnaires 11 Capecitabine 11 Blood Specimen Collection 11 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Biopsy 5 Bevacizumab 5 sintilimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02530411 2015-08-21

FURVA

Velindre NHS Trust

Phase 2 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡